The goal of Arphio, an orphan drug manufacturer, is to increase patient access to essential therapies for uncommon diseases. An accurate diagnosis of an orphan illness is thought to take a patient around seven years and ten visits to different doctors. At Arphio, we collaborate with the greatest professionals in the field to find treatments that are either under development or are only available in a few countries so that we can make them accessible worldwide.
DI, Drug manufacturer, Essential therapies
No funding announced yet
💡 You're a corporate or investor and looking for startups that are innovating in the same market as Arphio? We're happy to assist you with our Startup Sourcing service.